Bruker Spatial Genomics, Inc. (formerly Acuity Spatial Genomics, Inc.) provides a groundbreaking platform for simultaneous, visualization of the 3D genome in single cells and opens new frontiers in spatial omics analyses for discovery. Based on patented technologies developed at Harvard University, the company’s jebFISH™ technology empowers researchers to directly visualize genome organization and 3D chromatin architecture of individual cells, in situ, and in an expedient time-to-result approach.
The company’s transformative PaintScape™ platform, powered by jebFISH technology, breaks through challenges of multiplexed, direct imaging of the genome in nuclei in situ and makes it possible to gain critical insight into cell programming and transcription regulatory programs that drive cell type, state, and function. Directly seeing changes and disruptions of genome organization will elucidate mechanisms of disease and its progression especially in disease systems like cancer.
Bruker Spatial Genomics, Inc. is part of Bruker’s strategic investment in spatial biology and its initiative to develop and expand emerging spatial analyses technologies. The PaintScape platform joins the portfolio of high-performance Bruker Spatial Biology platforms that empower researchers to delve deeper and advance discovery in life science and translational research.
